Cannabis and Hemp Industry Investment News
Last year progressive voters were told that, despite the clear evidence that Joe Biden was a left-of-Reagan centrist, modern political pressures from ...
It challenges the conventional wisdom that the federal ban on marijuana gives legalization states free rein to discriminate against outsiders in their...
What should someone know before starting a cannabis business? To help aspiring entrepreneurs plan their own cannabis business, we asked business lead...
Key Points Planet 13 stock is over 30% below its peak from earlier this year. Business is booming for the cannabis company with even stronger growth l...
We believe Kathy Hochul may view cannabis as a popular initial (or near term) issue to champion at the start of her term thus gaining an initial win u...
A SECRETIVE United Nations body is in the process of drawing up its first ‘ill-informed’ Cannabis Initiative which may deliver a serious blow to the b...
First, cannabis dispensaries tried to channel the sophisticated look of an Apple Store. Now they’re embracing their inner Jimmy Buffett. It’s been a l...
THCVHS shows no signs of chromosomal or gene mutations in preclinical studies SAN DIEGO, CA, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye"), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat diseases with significant unmet need, has successfully completed genotoxicit...
SAN DIEGO, CA, July 26, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) ("SKYE" or the "Company"), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, has appointed Praveen Tyle, Ph.D., as an independent director to the Company's b...
SAN DIEGO, CA, June 10, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) ("SKYE" or the "Company"), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, has expanded its Clinical Advisory Board with the appointment of ophthalmology e...
LOS ANGELES and TORONTO, June 11, 2021 (GLOBE NEWSWIRE) -- The Tinley Beverage Company (CSE:TNY, OTC:TNYBF) ("Tinley's" or "Company") is pleased to announce that it has closed a C$2.4 million private placement to advance its co-packing and branded product growth. Closing occurred on June 10, 2021. The Company continues to make capital investments t...
LOS ANGELES and TORONTO, June 14, 2021 (GLOBE NEWSWIRE) -- The Tinley Beverage Company Inc. (CSE:TNY, OTC:TNYBF) ("Tinley's" or the "Company") is pleased to announce that its cannabis infused beverages will be one of the inaugural brands to launch at Planet 13's Orange County SuperStore "P13 OC" at its expected grand opening in July 2021. Planet 13...
LOS ANGELES and TORONTO, June 17, 2021 (GLOBE NEWSWIRE) -- The Tinley Beverage Company Inc. (CSE:TNY, OTC:TNYBF) ("Tinley's" or the "Company") is pleased to announce that California's longstanding favourite cannabis beverage "Sprig" will produce at Tinley's bottling facility in Long Beach, California. Sprig was founded in Newport Beach, California,...
Nextleaf Solutions, an extraction company that owns one of the largest portfolios of U.S. patents for the extraction and distillation of cannabinoids, with State B Cannabis Beverage Co. ("State B"), is pleased to announce details on the Canadian launch of State B beverages developed with Nextleaf's proprietary Rapid Emulsion Technology by OILS™ ("R...
Nextleaf Solutions Ltd. an extraction company that owns one of the largest portfolios of U.S. patents for the extraction and distillation of cannabinoids, is pleased to announce that it has signed a supply agreement with the British Columbia Liquor Distribution Branch ("BCLDB") for the sale and distribution of Nextleaf's cannabis oils and branded p...
